213 related articles for article (PubMed ID: 21445077)
1. Gene expression profiling in MDS and AML: potential and future avenues.
Theilgaard-Mönch K; Boultwood J; Ferrari S; Giannopoulos K; Hernandez-Rivas JM; Kohlmann A; Morgan M; Porse B; Tagliafico E; Zwaan CM; Wainscoat J; Van den Heuvel-Eibrink MM; Mills K; Bullinger L
Leukemia; 2011 Jun; 25(6):909-20. PubMed ID: 21445077
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling in acute myeloid leukemia.
Bullinger L; Valk PJ
J Clin Oncol; 2005 Sep; 23(26):6296-305. PubMed ID: 16155012
[TBL] [Abstract][Full Text] [Related]
3. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
Baldus CD; Bullinger L
Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
[TBL] [Abstract][Full Text] [Related]
4. Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?
Willman CL
Best Pract Res Clin Haematol; 2008 Mar; 21(1):21-8. PubMed ID: 18342809
[TBL] [Abstract][Full Text] [Related]
5. Genomics in myeloid leukemias: an array of possibilities.
Bullinger L; Döner H; Pollack JR
Rev Clin Exp Hematol; 2005 Jun; 9(1):E2. PubMed ID: 16027104
[TBL] [Abstract][Full Text] [Related]
6. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
8. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
Verhaak RG; Valk PJ
Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Swolin B; Rödjer S; Westin J
Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
[TBL] [Abstract][Full Text] [Related]
10. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
Estey E; Trujillo JM; Cork A; O'Brien S; Beran M; Kantarjian H; Keating M; Freireich EJ; Stass S
Hematol Pathol; 1992; 6(1):43-8. PubMed ID: 1601822
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies.
McDevitt MA
Semin Oncol; 2012 Feb; 39(1):109-22. PubMed ID: 22289497
[TBL] [Abstract][Full Text] [Related]
12. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
[TBL] [Abstract][Full Text] [Related]
13. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
[TBL] [Abstract][Full Text] [Related]
14. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
Vardiman JW
Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
[TBL] [Abstract][Full Text] [Related]
15. Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.
Cilloni D; Messa E; Messa F; Carturan S; Defilippi I; Arruga F; Rosso V; Catalano R; Bracco E; Nicoli P; Saglio G
Ann N Y Acad Sci; 2006 Nov; 1089():411-23. PubMed ID: 17261784
[TBL] [Abstract][Full Text] [Related]
16. Screening features to improve the class prediction of acute myeloid leukemia and myelodysplastic syndrome.
Li K; Yang M; Sablok G; Fan J; Zhou F
Gene; 2013 Jan; 512(2):348-54. PubMed ID: 23046576
[TBL] [Abstract][Full Text] [Related]
17. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
20. Distinct expression profiles of MSI2 and NUMB genes in myelodysplastic syndromes and acute myeloid leukemia patients.
Pereira JK; Traina F; Machado-Neto JA; Duarte Ada S; Lopes MR; Saad ST; Favaro P
Leuk Res; 2012 Oct; 36(10):1300-3. PubMed ID: 22784712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
